Japan, Sept. 3 -- EISAI R & D MANAGEMENT CO LTD has got intellectual property rights for 'METHOD FOR TREATING CANCER WITH ORAL DOSAGE FORM OF ESTROGEN RECEPTOR-ALPHA INHIBITOR.' Other related details are as follows:
Application Number: JP,2024-221279
Category (FI): A61K9/36,A61K47/04,A61K47/26,A61K47/38,A61K31/4439,A61K9/48,A61K47/12,A61K9/20,A61P35/00,A61K47/10,A61K47/02
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Dec. 18, 2024
Publication Date: March 18, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....